Download PDF
Semin Reprod Med 2010; 28(3): 204-217
DOI: 10.1055/s-0030-1251477
Published in 2010 by Thieme Medical Publishers

New Directions in the Epidemiology of Uterine Fibroids

Shannon K. Laughlin1 , Jane C. Schroeder2 , Donna Day Baird3
  • 1Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota
  • 2Environmental Health Perspectives, National Institute of Environmental Health Sciences, National Institutes of Health, Morrisville, North Carolina
  • 3Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina
Further Information

Publication History

Publication Date:
22 April 2010 (online)

    Permissions and Reprints

ABSTRACT

Although uterine leiomyomata (fibroids) have been the leading indication for hysterectomy in the United States for decades, the epidemiological data on fibroid prevalence and risk factors are limited. Given the hormonal dependence of fibroids, most earlier studies focused on reproductive or hormonal factors. Recent analyses have extended that focus to other areas. We present previously unpublished data on the association between reproductive tract infections and fibroids that highlight the need for more detailed studies. Our review suggests that metabolic, dietary, stress, and environmental factors may also play a role in fibroid development.

KEYWORDS

Uterine leiomyoma - epidemiology - reproductive tract infection - sexually transmitted disease - metabolic factors - diet - environment

REFERENCES

  • 1 Flake G P, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review.  Environ Health Perspect. 2003;  111(8) 1037-1054
    CrossrefPubMedGoogle Scholar
  • 2 Stewart E A. Uterine fibroids.  Lancet. 2001;  357(9252) 293-298
    CrossrefPubMedGoogle Scholar
  • 3 Pokras R, Hufnagel V G. Hysterectomy in the United States, 1965–84.  Am J Public Health. 1988;  78(7) 852-853
    CrossrefPubMedGoogle Scholar
  • 4 Farquhar C M, Steiner C A. Hysterectomy rates in the United States 1990–1997.  Obstet Gynecol. 2002;  99(2) 229-234
    CrossrefPubMedGoogle Scholar
  • 5 Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States.  Am J Obstet Gynecol. 2006;  195(4) 955-964
    CrossrefPubMedGoogle Scholar
  • 6 Schwartz S M, Marshall L M, Baird D D. Epidemiologic contributions to understanding the etiology of uterine leiomyomata.  Environ Health Perspect. 2000;  108(suppl 5) 821-827
    CrossrefPubMedGoogle Scholar
  • 7 Payson M, Leppert P, Segars J. Epidemiology of myomas.  Obstet Gynecol Clin North Am. 2006;  33(1) 1-11
    CrossrefPubMedGoogle Scholar
  • 8 Day Baird D, Dunson D B, Hill M C, Cousins D, Schectman J M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.  Am J Obstet Gynecol. 2003;  188(1) 100-107
    CrossrefPubMedGoogle Scholar
  • 9 Bower J K, Schreiner P J, Sternfeld B, Lewis C E. Black-white differences in hysterectomy prevalence: the CARDIA study.  Am J Public Health. 2009;  99(2) 300-307
    CrossrefPubMedGoogle Scholar
  • 10 Laughlin S K, Baird D D, Savitz D A, Herring A H, Hartmann K E. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study.  Obstet Gynecol. 2009;  113(3) 630-635
    CrossrefPubMedGoogle Scholar
  • 11 Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25–40 years.  Acta Obstet Gynecol Scand. 2000;  79(3) 202-207
    CrossrefPubMedGoogle Scholar
  • 12 Eskenazi B, Warner M, Samuels S et al.. Serum dioxin concentrations and risk of uterine leiomyoma in the Seveso Women's Health Study.  Am J Epidemiol. 2007;  166(1) 79-87
    CrossrefPubMedGoogle Scholar
  • 13 Luoto R, Kaprio J, Rutanen E M, Taipale P, Perola M, Koskenvuo M. Heritability and risk factors of uterine fibroids—the Finnish Twin Cohort study.  Maturitas. 2000;  37(1) 15-26
    CrossrefPubMedGoogle Scholar
  • 14 Parazzini F. Risk factors for clinically diagnosed uterine fibroids in women around menopause.  Maturitas. 2006;  55(2) 174-179
    CrossrefPubMedGoogle Scholar
  • 15 DeWaay D J, Syrop C H, Nygaard I E, Davis W A, Van Voorhis B J. Natural history of uterine polyps and leiomyomata.  Obstet Gynecol. 2002;  100(1) 3-7
    CrossrefPubMedGoogle Scholar
  • 16 Dixon D, Parrott E C, Segars J H, Olden K, Pinn V W. The second National Institutes of Health International Congress on advances in uterine leiomyoma research: conference summary and future recommendations.  Fertil Steril. 2006;  86(4) 800-806
    CrossrefPubMedGoogle Scholar
  • 17 Schwartz S M. Epidemiology of uterine leiomyomata.  Clin Obstet Gynecol. 2001;  44(2) 316-326
    CrossrefPubMedGoogle Scholar
  • 18 Purdie D M, Green A C. Epidemiology of endometrial cancer.  Best Pract Res Clin Obstet Gynaecol. 2001;  15(3) 341-354
    CrossrefPubMedGoogle Scholar
  • 19 Colditz G A. Epidemiology of breast cancer. Findings from the nurses' health study.  Cancer. 1993;  71(4, suppl) 1480-1489
    PubMedGoogle Scholar
  • 20 Guerrero-Bosagna C M, Sabat P, Valdovinos F S, Valladares L E, Clark S J. Epigenetic and phenotypic changes result from a continuous pre and post natal dietary exposure to phytoestrogens in an experimental population of mice.  BMC Physiol. 2008;  8 17
    CrossrefPubMedGoogle Scholar
  • 21 Baird D D, Dunson D B. Why is parity protective for uterine fibroids?.  Epidemiology. 2003;  14(2) 247-250
    CrossrefPubMedGoogle Scholar
  • 22 Wise L A, Palmer J R, Harlow B L et al.. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.  Am J Epidemiol. 2004;  159(2) 113-123
    CrossrefPubMedGoogle Scholar
  • 23 Walker C L, Cesen-Cummings K, Houle C, Baird D, Barrett J C, Davis B. Protective effect of pregnancy for development of uterine leiomyoma.  Carcinogenesis. 2001;  22(12) 2049-2052
    CrossrefPubMedGoogle Scholar
  • 24 Huyck K L, Panhuysen C I, Cuenco K T et al.. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters.  Am J Obstet Gynecol. 2008;  198(2) 168
    PubMedGoogle Scholar
  • 25 Marshall L M, Spiegelman D, Goldman M B et al.. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.  Fertil Steril. 1998;  70(3) 432-439
    CrossrefPubMedGoogle Scholar
  • 26 Lauchlin S K, Herring A H, Savitz D A et al.. Pregnancy-related fibroid reduction.  Fertil Steril. 2010;  , in press
    PubMedGoogle Scholar
  • 27 Peddada S D, Laughlin S K, Miner K et al.. Growth of uterine leiomyomata among premenopausal black and white women.  Proc Natl Acad Sci U S A. 2008;  105(50) 19887-19892
    CrossrefPubMedGoogle Scholar
  • 28 Burbank F. Childbirth and myoma treatment by uterine artery occlusion: do they share a common biology?.  J Am Assoc Gynecol Laparosc. 2004;  11(2) 138-152
    CrossrefPubMedGoogle Scholar
  • 29 Wise L A, Palmer J R, Harlow B L et al.. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study.  Hum Reprod. 2004;  19(8) 1746-1754
    CrossrefPubMedGoogle Scholar
  • 30 Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study.  Br J Obstet Gynaecol. 1996;  103(9) 909-914
    CrossrefPubMedGoogle Scholar
  • 31 Lethaby A E, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.  Cochrane Database Syst Rev. 2005;  (4) , CD002126
    PubMedGoogle Scholar
  • 32 Marshall L M, Spiegelman D, Barbieri R L et al.. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.  Obstet Gynecol. 1997;  90(6) 967-973
    CrossrefPubMedGoogle Scholar
  • 33 Chiaffarino F, Parazzini F, La Vecchia C, Chatenoud L, Di Cintio E, Marsico S. Diet and uterine myomas.  Obstet Gynecol. 1999;  94(3) 395-398
    CrossrefPubMedGoogle Scholar
  • 34 Nagata C, Nakamura K, Oba S, Hayashi M, Takeda N, Yasuda K. Association of intakes of fat, dietary fibre, soya isoflavones and alcohol with uterine fibroids in Japanese women.  Br J Nutr. 2009;  101(10) 1427-1431
    CrossrefPubMedGoogle Scholar
  • 35 Key J, Hodgson S, Omar R Z et al.. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues.  Cancer Causes Control. 2006;  17(6) 759-770
    CrossrefPubMedGoogle Scholar
  • 36 Friberg E, Wolk A. Long-term alcohol consumption and risk of endometrial cancer incidence: a prospective cohort study.  Cancer Epidemiol Biomarkers Prev. 2009;  18(1) 355-358
    CrossrefPubMedGoogle Scholar
  • 37 Terry K L, De Vivo I, Hankinson S E et al.. Anthropometric characteristics and risk of uterine leiomyoma.  Epidemiology. 2007;  18(6) 758-763
    CrossrefPubMedGoogle Scholar
  • 38 Marshall L M, Spiegelman D, Manson J E et al.. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking.  Epidemiology. 1998;  9(5) 511-517
    CrossrefPubMedGoogle Scholar
  • 39 Baird D D, Dunson D B, Hill M C, Cousins D, Schectman J M. Association of physical activity with development of uterine leiomyoma.  Am J Epidemiol. 2007;  165(2) 157-163
    CrossrefPubMedGoogle Scholar
  • 40 Takeda T, Sakata M, Isobe A et al.. Relationship between metabolic syndrome and uterine leiomyomas: a case-control study.  Gynecol Obstet Invest. 2008;  66(1) 14-17
    CrossrefPubMedGoogle Scholar
  • 41 Wise L A, Palmer J R, Spiegelman D et al.. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women.  Epidemiology. 2005;  16(3) 346-354
    CrossrefPubMedGoogle Scholar
  • 42 Azziz R. Reproductive endocrinologic alterations in female asymptomatic obesity.  Fertil Steril. 1989;  52(5) 703-725
    PubMedGoogle Scholar
  • 43 Wegienka G, Baird D D, Hertz-Picciotto I et al.. Self-reported heavy bleeding associated with uterine leiomyomata.  Obstet Gynecol. 2003;  101(3) 431-437
    CrossrefPubMedGoogle Scholar
  • 44 Hunskaar S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women.  Neurourol Urodyn. 2008;  27(8) 749-757
    CrossrefPubMedGoogle Scholar
  • 45 Witherspoon J T, Butler V W. The etiology of uterine fibroids with special reference to the frequency of their occurrence in the Negro: a hypothesis.  Surg Gynecol Obstet. 1934;  58 57-61
    PubMedGoogle Scholar
  • 46 Cohen S. Infection, cell proliferation, and malignancy. In: Parsonnet J Microbes and Malignancy Infection as a Cause of Human Cancers. New York, NY; Oxford University Press 1999: 89-106
    PubMedGoogle Scholar
  • 47 McClain K L, Leach C T, Jenson H B et al.. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS.  N Engl J Med. 1995;  332(1) 12-18
    CrossrefPubMedGoogle Scholar
  • 48 Stewart E A, Nowak R A. New concepts in the treatment of uterine leiomyomas.  Obstet Gynecol. 1998;  92(4 Pt 1) 624-627
    CrossrefPubMedGoogle Scholar
  • 49 Leppert P C, Catherino W H, Segars J H. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays.  Am J Obstet Gynecol. 2006;  195(2) 415-420
    CrossrefPubMedGoogle Scholar
  • 50 Cramer S F, Mann L, Calianese E, Daley J, Williamson K. Association of seedling myomas with myometrial hyperplasia.  Hum Pathol. 2009;  40(2) 218-225
    CrossrefPubMedGoogle Scholar
  • 51 Rogers R, Norian J, Malik M et al.. Mechanical homeostasis is altered in uterine leiomyoma.  Am J Obstet Gynecol. 2008;  198(4) 474
    PubMedGoogle Scholar
  • 52 Catherino W, Salama A, Potlog-Nahari C, Leppert P, Tsibris J, Segars J. Gene expression studies in leiomyomata: new directions for research.  Semin Reprod Med. 2004;  22(2) 83-90
    Article in Thieme ConnectPubMedGoogle Scholar
  • 53 Cramer S F, Padela A I, Marchetti C E, Newcomb P M, Heller D S. Myometrial hyperplasia in pediatric, adolescent, and young adult uteri.  J Pediatr Adolesc Gynecol. 2003;  16(5) 301-306
    CrossrefPubMedGoogle Scholar
  • 54 Finn O J. Cancer immunology.  N Engl J Med. 2008;  358(25) 2704-2715
    CrossrefPubMedGoogle Scholar
  • 55 Murta E F, Oliveira G P, Prado FdeO, De Souza M A, Tavares Murta B M, Adad S J. Association of uterine leiomyoma and Chagas' disease.  Am J Trop Med Hyg. 2002;  66(3) 321-324
    PubMedGoogle Scholar
  • 56 Faerstein E, Szklo M, Rosenshein N B. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation.  Am J Epidemiol. 2001;  153(1) 11-19
    CrossrefPubMedGoogle Scholar
  • 57 zur Hausen H. Papillomavirus infections—a major cause of human cancers.  Biochim Biophys Acta. 1996;  1288(2) F55-F78
    PubMedGoogle Scholar
  • 58 Lopez-Borges S, Gallego M I, Lazo P A. Recurrent integration of papillomavirus DNA within the human 12q14-15 uterine breakpoint region in genital carcinomas.  Genes Chromosomes Cancer. 1998;  23(1) 55-60
    CrossrefPubMedGoogle Scholar
  • 59 Wei J J, Chiriboga L, Mittal K. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata.  Fertil Steril. 2005;  84(2) 474-484
    CrossrefPubMedGoogle Scholar
  • 60 Klemke M, Meyer A, Nezhad M H et al.. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.  Genes Chromosomes Cancer. 2009;  48(2) 171-178
    CrossrefPubMedGoogle Scholar
  • 61 Baird D D, Kesner J S, Dunson D B. Luteinizing hormone in premenopausal women may stimulate uterine leiomyomata development.  J Soc Gynecol Investig. 2006;  13(2) 130-135
    CrossrefPubMedGoogle Scholar
  • 62 Cramer S F, Robertson Jr A L, Ziats N P, Pearson O H. Growth potential of human uterine leiomyomas: some in vitro observations and their implications.  Obstet Gynecol. 1985;  66(1) 36-41
    PubMedGoogle Scholar
  • 63 Baird D D, Travlos G, Wilson R et al.. Uterine leiomyomata in relation to insulin-like growth factor-I, insulin, and diabetes.  Epidemiology. 2009;  20(4) 604-610
    CrossrefPubMedGoogle Scholar
  • 64 Wise L A, Palmer J R, Stewart E A, Rosenberg L. Polycystic ovary syndrome and risk of uterine leiomyomata.  Fertil Steril. 2007;  87(5) 1108-1115
    CrossrefPubMedGoogle Scholar
  • 65 Walocha J A, Litwin J A, Miodoński A J. Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy.  Hum Reprod. 2003;  18(5) 1088-1093
    CrossrefPubMedGoogle Scholar
  • 66 Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer S A, Wright R. A prospective study of hypertension and risk of uterine leiomyomata.  Am J Epidemiol. 2005;  161(7) 628-638
    CrossrefPubMedGoogle Scholar
  • 67 Silver M A, Raghuvir R, Fedirko B, Elser D. Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling.  J Clin Hypertens (Greenwich). 2005;  7(11) 664-668
    CrossrefPubMedGoogle Scholar
  • 68 Settnes A, Andreasen A H, Jørgensen T. Hypertension is associated with an increased risk for hysterectomy: a Danish cohort study.  Eur J Obstet Gynecol Reprod Biol. 2005;  122(2) 218-224
    CrossrefPubMedGoogle Scholar
  • 69 Isobe A, Takeda T, Sakata M et al.. Dual repressive effect of angiotensin II- type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation.  Hum Reprod. 2008;  23(2) 440-446
    CrossrefPubMedGoogle Scholar
  • 70 Divisi D, Di Tommaso S, Salvemini S, Garramone M, Crisci R. Diet and cancer.  Acta Biomed. 2006;  77(2) 118-123
    PubMedGoogle Scholar
  • 71 Atkinson C, Lampe J W, Scholes D, Chen C, Wähälä K, Schwartz S M. Lignan and isoflavone excretion in relation to uterine fibroids: a case-control study of young to middle-aged women in the United States.  Am J Clin Nutr. 2006;  84(3) 587-593
    PubMedGoogle Scholar
  • 72 Terry K L, Missmer S A, Hankinson S E, Willett W C, De Vivo I. Lycopene and other carotenoid intake in relation to risk of uterine leiomyomata.  Am J Obstet Gynecol. 2008;  198(1) 37.e1-8
    PubMedGoogle Scholar
  • 73 Antoni M H, Lutgendorf S K, Cole S W et al.. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms.  Nat Rev Cancer. 2006;  6(3) 240-248
    Google Scholar
  • 74 Godbout J P, Glaser R. Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer.  J Neuroimmune Pharmacol. 2006;  1(4) 421-427
    CrossrefPubMedGoogle Scholar
  • 75 Lupien S J, McEwen B S, Gunnar M R, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition.  Nat Rev Neurosci. 2009;  10(6) 434-445
    CrossrefPubMedGoogle Scholar
  • 76 Figueredo V M. The time has come for physicians to take notice: the impact of psychosocial stressors on the heart.  Am J Med. 2009;  122(8) 704-712
    CrossrefPubMedGoogle Scholar
  • 77 Wise L A, Palmer J R, Cozier Y C et al.. Perceived racial discrimination and risk of uterine leiomyomata.  Epidemiology. 2007;  18(6) 747-757
    CrossrefPubMedGoogle Scholar
  • 78 Wirth M M, Meier E A, Fredrickson B L, Schultheiss O C. Relationship between salivary cortisol and progesterone levels in humans.  Biol Psychol. 2007;  74(1) 104-107
    CrossrefPubMedGoogle Scholar
  • 79 Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens.  Environ Health Perspect. 1995;  103(suppl 7) 83-87
    CrossrefPubMedGoogle Scholar
  • 80 Newbold R R, Moore A B, Dixon D. Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES).  Toxicol Pathol. 2002;  30(5) 611-616
    CrossrefPubMedGoogle Scholar
  • 81 Greathouse K L, Cook J D, Lin K et al.. Identification of uterine leiomyoma genes developmentally reprogrammed by neonatal exposure to diethylstilbestrol.  Reprod Sci. 2008;  15(8) 765-778
    CrossrefPubMedGoogle Scholar
  • 82 Baird D D, Newbold R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development.  Reprod Toxicol. 2005;  20(1) 81-84
    CrossrefPubMedGoogle Scholar
  • 83 Wise L A, Palmer J R, Rowlings K et al.. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure.  Obstet Gynecol. 2005;  105(1) 167-173
    CrossrefPubMedGoogle Scholar
  • 84 Gomez-Duran A, Carvajal-Gonzalez J M, Mulero-Navarro S, Santiago-Josefat B, Puga A, Fernandez-Salguero P M. Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling.  Biochem Pharmacol. 2009;  77(4) 700-712
    CrossrefPubMedGoogle Scholar
  • 85 Pevenstein S R, Williams R K, McChesney D, Mont E K, Smialek J E, Straus S E. Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia.  J Virol. 1999;  73(12) 10514-10518
    PubMedGoogle Scholar
  • 86 Zerr D M, Gooley T A, Yeung L et al.. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients.  Clin Infect Dis. 2001;  33(6) 763-771
    CrossrefPubMedGoogle Scholar
  • 87 Zerr D M, Huang M L, Corey L, Erickson M, Parker H L, Frenkel L M. Sensitive method for detection of human herpesviruses 6 and 7 in saliva collected in field studies.  J Clin Microbiol. 2000;  38(5) 1981-1983
    PubMedGoogle Scholar
  • 88 Lallemand F, Desire N, Rozenbaum W, Nicolas J C, Marechal V. Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay.  J Clin Microbiol. 2000;  38(4) 1404-1408
    PubMedGoogle Scholar

Donna Day BairdPh.D. 

Epidemiology Branch, A3-05, National Institute of Environmental Health Sciences

P.O. Box 12233, Research Triangle Park, NC 27709

Email: baird@niehs.nih.gov

      >